Latest Distributions News

BauMart Holdings reported steady progress in modular building and core divisions during Q4 2025, while maintaining disciplined cash management amid ongoing funding pressures.

Lefroy Exploration has transitioned its Lucky Strike Gold Mine from approvals to active mining, with first ore haulage and toll milling set for early 2026. Meanwhile, promising drilling results at the Burns Gold Project hint at further resource growth.

Blackpearl Group has reported a record-breaking Q3 FY26 with Annual Recurring Revenue soaring 114% year-on-year to $23.7 million, driven by strong organic growth across its multi-venture platform and the emergence of Data as a Service.

Klevo Rewards Limited has successfully reinstated its ASX listing and completed a $3.4 million capital raise, setting the stage for accelerated growth of its digital wallet and rewards platform.

Mount Ridley Mines has announced a maiden scandium mineral resource estimate of nearly 368 million tonnes at its Mount Ridley Project in Western Australia, positioning it among the world’s largest scandium deposits.

Simble Solutions reported steady cash flow and operational growth in Q4 FY25, alongside a strategic acquisition and capital raise to bolster its energy intelligence offerings.

Stakk Limited has surged to an $8.53 million annual recurring revenue run-rate in 2025, propelled by its acquisition of Radical DBX and strong SaaS growth. The fintech’s strategic moves position it for breakeven and further expansion in 2026.

Iron Road Ltd maintained modest spending on its Central Eyre Iron Project while progressing exploration at the Mulgathing Project, with key drilling results awaited. The company also updated its strategic land options at Cape Hardy amid subdued steel market conditions.

Core Energy Minerals has launched fully funded exploration at its newly acquired Itambe Rare Earth Element project in Brazil, targeting high-grade anomalies with maiden drilling planned for the second quarter of 2026.

Algorae Pharmaceuticals has advanced its AI drug discovery capabilities with the launch of AlgoraeOS v2 and secured key commercial partnerships, including a $3 million debt facility to support expansion in Australia and New Zealand.

Next Science Limited is set to distribute approximately A$0.145 per share following the sale of its assets to OSARTIS GmbH, marking a significant step towards winding down its operations.

Bioxyne Limited has reported a record $17.2 million in quarterly revenue, driven by strong growth in its cannabis and psychedelics segments, alongside strategic international expansions including a Frankfurt dual listing and new manufacturing agreements.